Provided by Tiger Trade Technology Pte. Ltd.

Ironwood Pharmaceuticals

4.29
+0.03500.82%
Volume:795.06K
Turnover:3.39M
Market Cap:705.37M
PE:5.43
High:4.32
Open:4.19
Low:4.18
Close:4.25
52wk High:5.78
52wk Low:1.01
Shares:164.61M
Float Shares:137.00M
Volume Ratio:0.66
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7890
EPS(LYR):0.1484
ROE:-574.72%
ROA:47.02%
PB:-4.36
PE(LYR):28.88

Loading ...

Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 30, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]